We evaluated coproporphyrin in the first urine passed by newborn infants with and without meconium aspiration, by spectrophotometric analysis and thin-layer and 'high-performance" liquid chromatography. Urines of newborn infants without meconium aspiration contained only very small quantities of coproporphyrin, detected, after partial purification, by "high-performance" liquid chromatography. Urines of newborn infants with meconium aspiration contained large quantities of coproporphyrin, identified by all three techniques. Urinary coproporphyrin as measured spectrophotometrically correlates well with the "urinary meconium index," and the method is simple, rapid, and reliable, even for samples containing hemoglobin.
The first urine passed by newborns with meconium aspiration shows an absorption peak at 405 nm. Using this observation as a starting point, we developed a rapid biochemical test for meconium aspiration, based on the determination of the urinary meconium index (UMI). When the value of the UMI exceeds 1, there probably has been meconium aspiration (1, 2). This test is unreliable when the urine contains hemoglobin, which gives a shift peak at 415 nm and makes impossible the direct spectrophotometry of about 10% of the urine specimens. Therefore we attempted to identify and to quantify the substance responsible for the peak at 405 nm, in an attempt to improve the specificity of the biochemical diagnosis of meconium aspiration. Coproporphyrin was investigated because it is present in mecomum (3) (4) (5) and has properties similar to those of substances contained in the first urine of newborns who have inhaled meconium-stained amniotic fluid: absorption in the Soret band between 400 and 410 nm and destruction by light (6, 7) .
Materials and Methods

Specimens
Urine specimens were collected from 74 male newborns admitted to the intensive-care unit. We obtained the first urine, uncontaminated with meconium, by attaching an adhesive bag to the infant at birth. These specimens were immediately frozen at -20 #{176}C and protected from light. After thawing, the UMI of each sample was determined as previously described (1, 2) . A test-strip method (Ames Division, Miles Laboratory, Inc., Elkhart, IN 46515) was used to identify urmnes containing hemoglobin, and such specimens were discarded.
Identification of Coproporphyrin
In the first stage of investigation, 10 urines of the 74 collected were selected for coproporphyrin identification. They were separated into two groups, each containing five specimens. For the first group (group I) the UMI values were <0.50; i.e., they were from newborns without meconium aspiration. The second group (group H) consisted of specimens with a UMI between 2 and 5, i.e., from newborns who had inhaled mecomum.
We used three different analytical techniques for the identification of coproporphyrin: spectrophotometry, thinlayer chromatography, and "high-performance" liquid chromatography. The samples were hydrochloric acid extracts obtained after selective extraction with diethyl ether of urine made acid with acetic acid accoiding to the method of Bellet (8) and Dobriner et al. (9) .
Both the samples and their hydrochloric extracts were examined spectrophotometrically between 380 and 430 nm, with a DB-GT spectrophotometer (Beckman Instruments Inc., Fullerton, CA 92634).
For the chromatographic analysis we used the lutidine method ( Further to identify the porphyrin, we added 1 mL of the hydrochloric acid extracts, corresponding to urine from groups land H, to 10 mL of a 95/5 (by vol) methanol/sulfuric acid mixture. After 12 h at ambient temperature, the mixture was filtered and the porphyrin methyl esters were extracted into 10 mL of chloroform, which was washed with four 100-mL portions of water, ifitered, and evaporated. 
Quantification of Coproporphyrin
In the second stage of the study, the amount of urinary coproporphyrin was determined on the 64 remaining samples by spectrophotometry in hydrochloric acid solution after extraction as previously described (8, 9) . This, briefly, is as follows. Two milliliters of urine, acidified with 0.4 mL 1.835
The factor 1.835 is the correction factor described by Rimington (7) . The correlation between UMI values and urinary coproporphyrin concentrations was measured.
Results Figure 1 shows the absorption spectra of one sample from group I (left) and one from group II (right) after selective extraction of coproporphyrin.
The samples had UMI values of 0.25 and 2.50, respectively.
The absorption spectra of all hydrochloric extracts in group H exhibited a peak at 402 nm. By contrast, no samples in group I had an absorption peak between 380 and 430 nm.
After thin-layer chromatography, the coproporphyrin standard was visible under ultraviolet light as a rosecolored fluorescent spot (RF 0.30). An identical spot was observed in the hydrochloric extracts of urine in group II and not in the urine extracts in group I. Adding coproporphyrin standard to the urine extracts in group H did not result in any additional spots on the chromatograin. Chromatograms obtained after "high-performance" liquid chromatography of the chloroform extracts showed that urine of both groups contained mainly coproporphyrin, but greater amounts of this porphyrin were present in the urines of group II (Figure 2 ). Figure 3 shows the good correlation between the values for UMI and urinary coproporphyrin, as obtained by the spectrophotometeric method. We determined that a concentration of urinary coproporphyrin of 130 nmolIL corresponds to a UMI value of 1.
To evaluate whether hemoglobin interferes with the spectrophotometric method, we measured the concentration of the coproporphyrin in urine from 10 newborn infants before and after adding hemoglobin (to give final concentrations of 0.15, 0.30, 0.60, and 1.20 gIL). This addition had no discernible effect. Urine containing 0.15 g of hemoglobin per liter did, however, give a highly positive reaction with the Ames test strip.
Discussion
Both meconium and old blood will stain amniotic fluid dark brown, so that clinical diagnosis based solely on the appearance of amniotic fluid is highly subjective. A reliable biochemical test for meconium staining would thus be welcomed by obstetricians.
In a previous study (1), we showed that the first urine passed by newborn infants who have inhaled meconiumstained amniotic fluid shows a characteristic peak at 405 nm. We suggested that this peak could have been produced by coproporphyrin, which is known to be present in meconium (4), and which might have crossed the alveolar barrier. We took particular care to avoid external contamination of our urine samples by meconium. Thus the peak at 405 nm that was demonstrated by our three different analytical methods must have resulted from the presence of urinary coproporphyrin.
Quantification of coproporphyrin in urine by "high-performance" liquid chromatography is time-consuming and requires special equipment. By contrast, spectrophotometry is simple, rapid, and reliable. It gives a good correlation with Ulvil values and should lead to an increase in the specificity of the biochemical diagnosis of meconial aspiration, even when the urine contains hemoglobin. 
